Autolus Therapeutics AUTL
NASDAQ AUTL
$1.86 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Non-Current Debt (2017 - 2019)

Updated

Autolus Therapeutics' Non-Current Debt was $30,000 in Q4 2019, down 75.2% from the prior quarter.

Analysis

Autolus Therapeutics (AUTL) Non-Current Debt (2017 - 2019) Analysis & Trends

From Q4 2017 onward, Autolus Therapeutics has reported Non-Current Debt for 4 quarters.

  • In earlier years, Non-Current Debt was $285,000 in FY2018 and $763,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Autolus Therapeutics 660.38 Mn -663.71 Mn 25.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 30,000.00
Jun 30, 2019 121,000.00
Dec 31, 2018 285,000.00
Sep 30, 2018 380,000.00
Sep 30, 2017 763,000.00
API Access

Autolus Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=AUTL&period=max&api_key=YOUR_API_KEY